在智力障碍的成年人中使用药:制定处方指南
Ruth Bishop1, Richard Laugharne2, Lisa Burrows3
1Cornwall Intellectual Disability Equitable Research (CIDER), Cornwall Partnership NHS Foundation Trust, Truro, UK; and CIDER, University of Plymouth Peninsula School of Medicine, Truro, UK.
BJPsych open
|April 18, 2024
概括
新的指导方针针对智力障碍患者的药处方,旨在改善护理并确保适当的治疗. 这项研究涉及专家和有实践经验的人,以创建基于证据的建议.
科学领域:
- 临床实践指南 临床实践指南
- 智力障碍研究 智力障碍研究
- 胃肠病学 胃肠病学
背景情况:
- 在智力障碍患者中,便秘很普遍,药使用率很高.
- 人们对当前的药处方实践对这一群体的有效性和适当性存在担忧.
- 对于智力障碍患者的药,缺乏具体的处方指南.
研究的目的:
- 为临床医生制定基于证据的指导方针,为智力残疾人开药.
- 支持对这个人口群体进行药治疗的知情决策.
主要方法:
- 使用了经过修改的Delphi方法 (RAND/UCLA适当性方法).
- 一个专家小组,包括专业人士和智力障碍者 (经验专家) 参与.
- 通过问卷和虚拟/面对面会议建立共识.
主要成果:
- 20名参与者 (10名专家,10名经验专家) 提供了贡献.
- 关键的共识领域包括诊断,处方角色,管理实用性,监测和沟通.
- 确定了制定指导方针的五个主要领域.
结论:
- 成功制定了药处方指南.
- 这些指南综合了专家知识和现有证据.
- 其目的是加强对经历便秘的智力障碍患者的患者护理.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
161
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
161
Drugs Affecting GI Tract Motility: Other Laxatives
202
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
202
Drugs for Treatment of Diarrhea-Predominant IBS
163
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
163
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
207
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
207
Irritable Bowel Syndrome III: Medical and Nursing Management
198
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
198
Intellectual Disability
49
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
49


